MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-09-2026
Neogen Corporation Cash and Cash Equivalents 2011-2026 | NEOG
Annual Cash and Cash Equivalents Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 M | 171 M | 163 M | 44.5 M | 75.6 M | 66.3 M | 41.7 M | 83.1 M | 77.6 M | 55.3 M | 66.1 M | 40.7 M | 50 M | 49 M | 35.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 171 M | 35.8 M | 76.6 M |
Quarterly Cash and Cash Equivalents Neogen Corporation
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160 M | 145 M | 139 M | 129 M | 128 M | 140 M | 120 M | 171 M | 161 M | 206 M | 179 M | 163 M | 67.1 M | 100 M | 107 M | 44.5 M | 42.9 M | 51.1 M | 71.3 M | 75.6 M | 75.6 M | 114 M | 60.9 M | 114 M | 50.8 M | 66.4 M | 56.3 M | 66.4 M | 56.3 M | 102 M | 97.2 M | 102 M | 97.2 M | 64.4 M | 58.5 M | 64.4 M | 58.5 M | 86.3 M | 76.2 M | 86.3 M | 76.2 M | 71.4 M | 42.3 M | 71.4 M | 42.3 M | 49.1 M | 53.5 M | 49.1 M | 53.5 M | 43.6 M | 43.6 M | 43.6 M | 43.6 M | 41.3 M | 44.5 M | 41.3 M | 44.5 M | 37 M | 22 M | 37 M | 22 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 206 M | 22 M | 80.8 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
420 M | $ 203.78 | -0.37 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
166 M | $ 88.24 | -4.7 % | $ 4.13 B | USA |
 |
Fulgent Genetics
FLGT
|
50.2 M | $ 18.93 | 2.32 % | $ 583 M | USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
11.9 M | $ 4.88 | 8.44 % | $ 6.49 M | USA |
 |
Castle Biosciences
CSTL
|
117 M | $ 21.08 | - | $ 611 M | USA |
 |
Aspira Women's Health
AWH
|
1.76 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
15.1 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
378 M | $ 130.7 | 0.45 % | $ 16.4 B | USA |
 |
CareDx, Inc
CDNA
|
65.4 M | $ 23.46 | 3.12 % | $ 1.25 B | USA |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
647 M | $ 144.59 | -4.76 % | $ 11.3 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
2 K | - | - | $ 9.42 M |  Israel |
 |
Illumina
ILMN
|
1.42 B | $ 162.47 | 1.52 % | $ 25.2 B | USA |
 |
Interpace Biosciences
IDXG
|
2.5 M | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.02 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
359 M | $ 100.24 | 0.26 % | $ 6.77 B | USA |
 |
Charles River Laboratories International
CRL
|
214 M | $ 186.29 | -1.88 % | $ 9.23 B | USA |
 |
Medpace Holdings
MEDP
|
497 M | $ 465.73 | -0.23 % | $ 13.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
956 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
66.9 M | $ 1 133.03 | -2.56 % | $ 23.4 B |  Schweiz |
 |
NeoGenomics
NEO
|
160 M | $ 11.28 | -1.4 % | $ 1.44 B | USA |
 |
Myriad Genetics
MYGN
|
150 M | $ 4.43 | -2.42 % | $ 410 M | USA |
 |
National Research Corporation
NRC
|
4.14 M | $ 21.28 | 7.75 % | $ 476 M | USA |
 |
Natera
NTRA
|
1.08 B | $ 216.5 | -2.84 % | $ 29.6 B | USA |
 |
Pacific Biosciences of California
PACB
|
63.7 M | $ 1.37 | - | $ 411 M | USA |
 |
Personalis
PSNL
|
124 M | $ 9.61 | -1.44 % | $ 858 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.79 B | $ 25.67 | -3.13 % | $ 24.3 B |  Niderland |
 |
Senseonics Holdings
SENS
|
40.2 M | $ 7.3 | -1.75 % | $ 305 M | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
70.1 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.02 | -1.51 % | $ 4.64 M | USA |
 |
Twist Bioscience Corporation
TWST
|
183 M | $ 67.77 | -3.27 % | $ 4.05 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
532 M | $ 268.63 | -0.96 % | $ 22.4 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.85 B | $ 482.04 | -2.43 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
5.17 M | $ 0.69 | 3.51 % | $ 248 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Invitae Corporation
NVTA
|
257 M | - | - | $ 21.2 M | USA |